EORTC Cancer Research Fund
Help drive critical clinical cancer research and give hope to patients and loved ones.
The European Organisation for Research and Treatment of Cancer (EORTC) is an
academic clinical research organisation, which unites cancer research
experts across the globe to define better treatments for patients to prolong survival and improve quality of life. Both international and multidisciplinary, EORTC’s network comprises of over 3,800 members involved in cancer treatment and research in more than 1,000 institutions across 58 countries. Conducting translational research, and phase 2 and 3 trials, EORTC offers an integrated approach to therapeutic strategies and quality of life. EORTC Headquarters, a unique international clinical research infrastructure, are based in Brussels, Belgium, from where its various activities are coordinated and run.
EORTC pushes the boundaries of treatment options to improve patient care. Spanning all cancer types and treatments as well as working across borders, we are currently engaged in 150 trials at distinct stages of development including several practice-changing trials.
The EORTC Cancer Research Fund (ECRF) is the funding arm of this scientific organization with a mission to promote, encourage and support research on the treatment of cancer under the auspices of the EORTC. Unlike commercially driven research, ECRF supports academic clinical cancer research that prioritises therapeutic progress for patients—not profit.
Fundraisers
Official fundraiser
Give hope through urgent clinical cancer research
Cancer patients deserve hope —regardless of their diagnosis, background, or rarity of their tumour.
At EORTC, we are committed to ensuring that within the realms of our research , no patient group is overlooked. This year, thanks to the support of EORTC Cancer Research Fund’s valued donors and partners, we’ve made meaningful strides in:
• Rare cancer research-addressing unique challenges faced by patients, including limited access to clinical trials and new drugs, whilst offering effective treatment options where there may have been few, before;
• Bringing hope to diverse groups of people through inclusive clinical trials - ensuring research reflects the diversity of those affected;
• Optimising treatments -tailoring treatments to patient’s needs, de-escalating and reducing toxicity and side effects to improve long-term quality of life. Your donations to EORTC help fight the war against cancer to the benefit of millions of people in both in Europe and the entire world. We simply cannot thank you enough. Patient Advocate-Pete Wheatstone, bowel cancer survival As this year draws to a close, please help us maintain momentum. Your gift to EORTC Cancer Research Fund supports inclusive trials, gives hope to those diagnosed with rare tumours, and ensures smarter treatments. Thank you.
- Raised
- $0
- Next milestone
- $100
